NO GENERIC
ADEQUAN
®
Get the facts at
www.nogenericadequan.com
There is
BRIEF SUMMARY :
Adequan
®
i.m.: For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in
horses. There are no known contraindications to the use of intramuscular Adequan
®
i.m. brand Polysulfated Glycosaminoglycan in horses. Studies have not been conducted to
establish safety in breeding horses. Each 5 mL contains 500 mg Polysulfated Glycosaminoglycan. WARNING: Do not use in horses intended for human consumption. Not for
use in humans. Keep this and all medications out of the reach of children. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Adequan
®
I.A.: For the intra-articular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal joint in horses.
Inflammatory joint reactions and septic arthritis have been reported following administration of Adequan
®
I.A. Joint sepsis, a rare but potentially life threatening complication,
can occur after intra-articular injection. Use only in the carpal joint of horses. Each 1 mL contains 250 mg Polysulfated Glycosaminoglycan. WARNING: Do not use in horses
intended for human consumption. Keep this and all medications out of the reach of children. Caution: Federal law restricts this drug to use by or on the order of a licensed
veterinarian.
SEE PRODUCT PACKAGE INSERTS FOR FULL PRESCRIBING INFORMATION. Adequan
®
is a registered trademark of
Luitpold Pharmaceuticals, Inc. ©LUITPOLD PHARMACEUTICALS, INC., Animal Health Division, Shirley, NY 11967.
AHD 010, Rev. 1/2014
